Used as a potent inhibitor in cancer therapy, particularly targeting tumor cell proliferation by modulating specific kinase pathways involved in cell growth and survival. It shows promising activity in preclinical models for hematologic malignancies due to its ability to selectively interfere with signaling cascades in cancer cells. Its structural configuration enhances blood-brain barrier penetration, making it suitable for evaluating central nervous system malignancies. Currently investigated in early-stage oncology research for its efficacy and safety profile in targeted treatments.